Amniotic Membrane Market Size to Grow by USD 954.86 Million | Extensive Use of Amniotic Membrane Transplantation in Ophthalmic Surgeries to Boost Market Growth | 17,000+ Technavio Research Reports – Press Release

NEW YORK, June 17, 2022 /PRNewswire/ — The “Amniotic Membrane Market by Type and Geography – Forecast and Analysis 2021-2025” report has been added to Technavio’s offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.

The potential growth difference for the amniotic membrane market between 2020  and 2025 is USD 954.86 million, as per the latest market analysis report by Technavio. The report also predicts the market to witness an accelerating growth momentum at a CAGR of 12.01% during the predicted period.

Key Market Dynamics:

• Market Driver: The extensive use of amniotic membrane transplantation in ophthalmic surgeries is a major factor driving the global amniotic membranes market share growth. Ocular surface reconstruction procedures have significantly improved due to the characteristic properties of amniotic membranes that facilitate the migration of epithelial cells, reinforce cellular adhesion, and encourage epithelial diffraction. Additionally, amniotic membranes can modulate stromal scarring and have anti-inflammatory properties. Such eye infections and disorders increase the demand for ophthalmic reconstruction surgeries across the globe, thereby driving the growth of amniotic membrane products.
• Market Challenge: The limited supply of amniotic membranes will be a major challenge for the global amniotic membranes market share growth during the forecast period. The demand for amniotic membranes has risen owing to their increasing adoption. Amniotic membranes can only be retrieved from donors that have previously been screened serologically for the detection of any potential communicable disease. This further limit the availability of sources and creates a considerable gap in demand and supply, which results in higher dependency of market vendors on cryopreservation facilities and further aids the storage cost.

Revenue-generating Segment Highlights:

The amniotic membrane market report is segmented by Type (cryopreserved amniotic membrane and dehydrated amniotic membrane) and Geography (North America, Europe, Asia, and ROW).  

The cryopreserved amniotic membrane type segment held the largest market share in 2020. The segment is anticipated to account for the highest revenue throughout the forecast period. The growth of the segment can be attributed to their wide applications such as in anti-inflammatory therapies and regenerative procedures that are largely enhanced due to the substantial availability of biological components. 

North America will be the leading region with 54% of the market’s growth during the forecast period.  The US is the key market for amniotic membrane market in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW. The growing adoption of advanced wound care treatments due to substantial awareness of improved healthcare options among people will propel the amniotic membrane market growth in North America over the forecast period.

Some Companies Mentioned with their Offerings

• Celularity Inc.
• Human Regenerative Technologies LLC
• Integra LifeSciences Holdings Corp.
• Katena Products Inc.
• MiMedx Group Inc.
• NuVision Biotherapies Ltd.
• Orthofix Medical Inc.
• Stryker Corp.
• Surgenex LLC
• TissueTech Inc.
• To gain access to more vendor profiles with their key offerings available with Technavio, Click Here

Related Reports:

Collagen Supplement Market by Distribution Channel and Geography – Forecast and Analysis 2022-2026

Vitiligo Therapeutics Market by Route of Administration and Geography – Forecast and Analysis 2022-2026

Key Topics Covered:

1 Executive Summary

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 01: Parent market
• Exhibit 02: Market characteristics

• 2.2 Value chain analysis
• Exhibit 03: Value chain analysis for pharmaceuticals market

3 Market Sizing

• 3.1 Market definition
• Exhibit 04: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 05: Market segments

• 3.4 Market outlook: Forecast for 2020 – 2025
• Exhibit 06: Global – Market size and forecast 2020 – 2025 ($ million)
• Exhibit 07: Global market: Year-over-year growth 2020 – 2025 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 08: Five forces analysis 2020 & 2025

• 4.2 Bargaining power of buyers
• Exhibit 09: Bargaining power of buyers

• 4.3 Bargaining power of suppliers
• Exhibit 10: Bargaining power of suppliers

• 4.4 Threat of new entrants
• Exhibit 11: Threat of new entrants

• 4.5 Threat of substitutes
• Exhibit 12: Threat of substitutes

• 4.6 Threat of rivalry
• Exhibit 13: Threat of rivalry

• 4.7 Market condition
• Exhibit 14: Market condition – Five forces 2020

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 15: Type – Market share 2020-2025 (%)

• 5.2 Comparison by Type
• Exhibit 16: Comparison by Type

• 5.3 Cryopreserved amniotic membrane – Market size and forecast 2020-2025
• Exhibit 17: Cryopreserved amniotic membrane – Market size and forecast 2020-2025 ($ million)
• Exhibit 18: Cryopreserved amniotic membrane – Year-over-year growth 2020-2025 (%)

• 5.4 Dehydrated amniotic membrane – Market size and forecast 2020-2025
• Exhibit 19: Dehydrated amniotic membrane – Market size and forecast 2020-2025 ($ million)
• Exhibit 20: Dehydrated amniotic membrane – Year-over-year growth 2020-2025 (%)

• 5.5 Market opportunity by Type
• Exhibit 21: Market opportunity by Type

6 Customer landscape

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 23: Market share by geography 2020-2025 (%)

• 7.2 Geographic comparison
• Exhibit 24: Geographic comparison

• 7.3 North America – Market size and forecast 2020-2025
• Exhibit 25: North America – Market size and forecast 2020-2025 ($ million)
• Exhibit 26: North America – Year-over-year growth 2020-2025 (%)

• 7.4 Europe – Market size and forecast 2020-2025
• Exhibit 27: Europe – Market size and forecast 2020-2025 ($ million)
• Exhibit 28: Europe – Year-over-year growth 2020-2025 (%)

• 7.5 Asia – Market size and forecast 2020-2025
• Exhibit 29: Asia – Market size and forecast 2020-2025 ($ million)
• Exhibit 30: Asia – Year-over-year growth 2020-2025 (%)

• 7.6 ROW – Market size and forecast 2020-2025
• Exhibit 31: ROW – Market size and forecast 2020-2025 ($ million)
• Exhibit 32: ROW – Year-over-year growth 2020-2025 (%)

• 7.7 Key leading countries
• Exhibit 33: Key leading countries

• 7.8 Market opportunity by geography
• Exhibit 34: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.2 Market challenges
• Exhibit 35: Impact of drivers and challenges

9 Vendor Landscape

• 9.2 Vendor landscape
• Exhibit 36: Vendor landscape

• 9.3 Landscape disruption
• Exhibit 37: Landscape disruption
• Exhibit 38: Industry risks

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 39: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 40: Market positioning of vendors

• 10.3 Celularity Inc.
• Exhibit 41: Celularity Inc. – Overview
• Exhibit 42: Celularity Inc. – Product and service
• Exhibit 43: Celularity Inc. – Key news
• Exhibit 44: Celularity Inc. – Key offerings

• 10.4 Human Regenerative Technologies LLC
• Exhibit 45: Human Regenerative Technologies LLC – Overview
• Exhibit 46: Human Regenerative Technologies LLC – Product and service
• Exhibit 47: Human Regenerative Technologies LLC – Key offerings

• 10.5 Integra LifeSciences Holdings Corp.
• Exhibit 48: Integra LifeSciences Holdings Corp. – Overview
• Exhibit 49: Integra LifeSciences Holdings Corp. – Business segments
• Exhibit 50: Integra LifeSciences Holdings Corp. – Key news
• Exhibit 51: Integra LifeSciences Holdings Corp. – Key offerings
• Exhibit 52: Integra LifeSciences Holdings Corp. – Segment focus

• 10.6 Katena Products Inc.

• 10.7 MiMedx Group Inc.
• Exhibit 57: MiMedx Group Inc. – Overview
• Exhibit 58: MiMedx Group Inc. – Business segments
• Exhibit 59: MiMedx Group Inc. – Key news
• Exhibit 60: MiMedx Group Inc. – Key offerings

• 10.8 NuVision Biotherapies Ltd.
• Exhibit 61: NuVision Biotherapies Ltd. – Overview
• Exhibit 62: NuVision Biotherapies Ltd. – Product and service
• Exhibit 63: NuVision Biotherapies Ltd. – Key offerings

• 10.9 Orthofix Medical Inc.
• Exhibit 64: Orthofix Medical Inc. – Overview
• Exhibit 65: Orthofix Medical Inc. – Business segments
• Exhibit 66: Orthofix Medical Inc. – Key news
• Exhibit 67: Orthofix Medical Inc. – Key offerings
• Exhibit 68: Orthofix Medical Inc. – Segment focus

• 10.10 Stryker Corp.
• Exhibit 69: Stryker Corp. – Overview
• Exhibit 70: Stryker Corp. – Business segments
• Exhibit 71: Stryker Corp. – Key news
• Exhibit 72: Stryker Corp. – Key offerings
• Exhibit 73: Stryker Corp. – Segment focus

• 10.11 Surgenex LLC
• Exhibit 74: Surgenex LLC – Overview
• Exhibit 75: Surgenex LLC – Product and service
• Exhibit 76: Surgenex LLC – Key offerings

• 10.12 TissueTech Inc.
• Exhibit 77: TissueTech Inc. – Overview
• Exhibit 78: TissueTech Inc. – Product and service
• Exhibit 79: TissueTech Inc. – Key news
• Exhibit 80: TissueTech Inc. – Key offerings

11 Appendix

• 11.2 Currency conversion rates for US$
• Exhibit 81: Currency conversion rates for US$

• 11.3 Research methodology
• Exhibit 82: Research Methodology
• Exhibit 83: Validation techniques employed for market sizing
• Exhibit 84: Information sources

• 11.4 List of abbreviations
• Exhibit 85: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/amniotic-membrane-market-size-to-grow-by-usd-954-86-million–extensive-use-of-amniotic-membrane-transplantation-in-ophthalmic-surgeries-to-boost-market-growth–17-000-technavio-research-reports-301570098.html

SOURCE Technavio